In addition to buzzy ingredients like exosomes and PDRN, growth factor serums are another type of futuristic formula on the ...

Gain insights into Ligand Pharmaceuticals' strong Q1 2025 performance, with 46% revenue growth, strategic investments, and a robust outlook for ...

Ligand Pharmaceuticals Inc (NASDAQ:LGND) reported a 46% increase in top-line revenue and an 11% growth in adjusted EPS for Q1 2025. The company has a strong cash position with over $200 million in ...

As a proof-of-principle, we screened human endothelial cells stimulated with vascular endothelial growth factor (VEGF) and constructed a peptide-based ligand-receptor map of the VEGF family.

Patients in the ivonescimab group demonstrated a significantly greater progression-free survival than those in the ...

Which ligand binds which receptor and what partner ... when Rita Levi-Montalcini discovered a soluble substance called nerve growth factor (NGF) and Stanley Cohen discovered something quite ...